Randomized, controlled trial of telcagepant for the acute treatment of migraine.
about
Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraineMigraine in the era of precision medicineCGRP as a neuropeptide in migraine: lessons from miceThe TRPA1 channel in migraine mechanism and treatmentCalcitonin gene-related peptide: physiology and pathophysiologyEndosomal proteolysis regulates calcitonin gene-related peptide responses in mesenteric arteriesCalcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation.A Potential Preclinical Migraine Model: CGRP-Sensitized Mice.Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974).Possible sites of action of the new calcitonin gene-related peptide receptor antagonists.Therapeutic effects and safety of olcegepant and telcagepant for migraine: A meta-analysis.Nocebo is the enemy, not placebo. A meta-analysis of reported side effects after placebo treatment in headaches.Possible site of action of CGRP antagonists in migraine.One hundred years of migraine research: major clinical and scientific observations from 1910 to 2010.Diencephalic and brainstem mechanisms in migraine.The Dose Proportionality of Telcagepant after Administration of Single Oral and Intravenous Doses in Healthy Adult SubjectsCGRP receptor antagonists: an expanding drug class for acute migraine?Neurologic bases for comorbidity of balance disorders, anxiety disorders and migraine: neurotherapeutic implicationsCalcitonin gene-related peptide (CGRP): a new target for migraineCalcitonin gene-related peptide antagonism for acute treatment of migraine: a meta-analysis.Epigenetic regulation of the calcitonin gene-related peptide gene in trigeminal glia.Randomized clinical trial of intravenous valproate (orifil) and dexamethasone in patients with migraine disorderCGRP receptor antagonism and migraine.CGRP and migraine: could PACAP play a role too?Reactive oxygen species induce procalcitonin expression in trigeminal ganglia gliaProphylactic Treatment of Migraine.Calcitonin gene-related peptide receptor antagonists for migraine.Optimal balance of efficacy and tolerability of oral triptans and telcagepant: a review and a clinical comment.Chemical mediators of migraine: preclinical and clinical observations.CONSORT recommendations in abstracts of randomised, controlled trials on migraine and headacheTargeting a family B GPCR/RAMP receptor complex: CGRP receptor antagonists and migraine.CGRP and NO in the trigeminal system: mechanisms and role in headache generation.The pipeline in headache therapy.Discovery techniques for calcitonin gene-related peptide receptor antagonists for potential antimigraine therapies.Emerging targets in migraine.Efficacy, safety, and tolerability of telcagepant in the treatment of acute migraine: a meta-analysis.Calcitonin gene-related peptide targeted immunotherapy for migraine: progress and challenges in treating headache.Monoclonal antibodies for migraine: preventing calcitonin gene-related peptide activity.New treatments for headache.Emerging drugs for migraine treatment.
P2860
Q24632671-9F987534-1D98-4FE8-BF77-86E0B84D6872Q26748947-DB62E9AB-AB7B-402C-B34C-09C3CC190928Q26821821-79A50CDA-0669-4BD3-B605-8C414986402FQ27016641-FAB45E67-9619-4FF1-8EE3-62D2AAA34A77Q28249298-684EF42C-5530-461C-9AE2-9D0996058830Q28577195-2415D88B-A143-4DDE-A426-E2C0504CD796Q30466408-A540C082-94DB-4895-8477-47EA2EAA301FQ30482553-CE80FAB8-F731-4316-B8F2-03C20EDCCD81Q33524521-67EAB5D7-FCA7-49BE-8C28-07CC97BB448AQ33778781-2AF53516-EA2B-477C-8BFB-5D7E67130815Q34094599-C5233270-B988-48FB-8F09-14DA601E7109Q34158126-CBB6E1E2-9D5A-46FE-9CAB-338964CEF32EQ34169056-35CBE227-9407-44B5-BBDC-74BEE5E24421Q34180539-44605679-BBE0-4F85-AFE6-06810A87BF0EQ34217686-F286B408-2D4F-4A2C-BA3E-3DD2D1A620DFQ34462428-FE8989D9-66BC-47C8-ABF2-C258538733B9Q34637610-652A17D1-BB15-4847-BA14-CDC9FDFBB18EQ35023333-832F94C1-70B1-46D6-A3DD-8F1B253F5ED3Q35358428-5678065B-4A27-485A-BCEA-853F81784CAEQ35884646-D8E684D3-7AFF-45EF-BCD5-FDBF3DA13352Q36060346-10341C6C-5A2F-4699-BA9B-91FDA8821705Q37165948-2E552B68-A52D-458B-8DBC-4C0DF94F37A9Q37374122-CAF74442-BD85-4030-B2D4-822CA257FCA3Q37384128-0BEACA71-34AE-491F-969D-6DCB337454A6Q37627012-CC3847C4-019D-4636-A405-B85D7C5910CEQ37703845-02A0F5F3-CEE8-4205-8B8C-B1667F3C28E0Q37756158-9F60B2DA-05FC-4105-B337-69E3782DA1EDQ37847067-66067BE5-F335-4650-8265-5176D610E479Q37883455-83356313-F849-46A2-997F-957E07A071E0Q37895178-E402F4E3-ADB9-4492-9A92-249B2FA0FEF6Q37922799-862594FA-276D-4F82-9308-3F529DCA8D3FQ38025661-FBC8778C-33E8-47F6-BE10-6FE831A2B793Q38120491-5A9D23D7-820F-4F78-A60E-BA33090D1C2FQ38130336-83B4D119-88A6-4BD5-94AB-8A7908CED8A5Q38169593-AE671346-8052-4FB4-BE1E-E03A8FA6125EQ38175067-01F0B888-BF96-482F-8B2C-2D342BA3A8A1Q38180998-5009DE4D-6F32-40EF-B863-97B14004D75CQ38196732-DFC2E581-2756-4B3F-B466-607B8F36F6D0Q38215470-CA2F91EF-E548-4771-AB72-460D389AA14FQ38303376-CC8D459F-24D0-42ED-B46B-4838CC1AA8E4
P2860
Randomized, controlled trial of telcagepant for the acute treatment of migraine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Randomized, controlled trial of telcagepant for the acute treatment of migraine.
@en
Randomized, controlled trial of telcagepant for the acute treatment of migraine.
@nl
type
label
Randomized, controlled trial of telcagepant for the acute treatment of migraine.
@en
Randomized, controlled trial of telcagepant for the acute treatment of migraine.
@nl
prefLabel
Randomized, controlled trial of telcagepant for the acute treatment of migraine.
@en
Randomized, controlled trial of telcagepant for the acute treatment of migraine.
@nl
P2093
P2860
P1433
P1476
Randomized, controlled trial of telcagepant for the acute treatment of migraine.
@en
P2093
H-C Diener
K M Connor
R E Shapiro
P2860
P304
P356
10.1212/WNL.0B013E3181B87942
P407
P50
P577
2009-09-01T00:00:00Z